Novartis

Latest articles

14h
New Kerala
Erelzi (etanercept), by Sandoz, is now available for patients in Canada for the treatment of multiple inflammatory diseases - newkerala news #265034BOUCHERVILLE, QC, Aug. 21, 2017 /CNW Telbec/ - Sandoz, a Novartis division and
New Kerala / Posted 14 hours ago
BOUCHERVILLE, QC, Aug. 21, 2017 /CNW Telbec/ - Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announced today that ErelziTM (etanercept) is now available in Canada. In April 2017, Health Canada granted ErelziTM a Notice... Read more
15h
The Scientist
Custom-Made Moleculesto make oligos, popped them and the sequence data into the machine, and the nex
The Scientist / Posted 15 hours ago
to make oligos, popped them and the sequence data into the machine, and the next morning the genes were ready to ship to Novartis for RNA vaccine production. The process was quick, but it could certainly have been quicker, Gibson says. “I... Read more
18h
Swissinfo
Novartis Speeds New Anti-Malarial as Older Drug Loses Potency(Bloomberg) -- Novartis AG began testing a new anti-malaria pill in Africa, adv
Swissinfo / Posted 18 hours ago
(Bloomberg) -- Novartis AG began testing a new anti-malaria pill in Africa, advancing development of an alternative to its most effective treatment that billionaire philanthropist Bill Gates said risked losing potency. Patients in Mali infected with... Read more
19h
Arkansas Democrat-Gazette
Insurers' pacts set barriers to drugsamong other factors, can lower the drug's actual sale price. Other biosimilars
Arkansas Democrat-Gazette / Posted 19 hours ago
among other factors, can lower the drug's actual sale price. Other biosimilars have taken time to get traction. When Novartis division Sandoz launched white-blood-cell booster Zarxio, the first biosimilar approved in the U.S., two years ago,... Read more
1d
The Border Mail
Drug companies paying doctors millions for 'educational' events, consultanciesbetween October 2015 and April this year, the data shows. Some of the biggest
The Border Mail / Posted yesterday
between October 2015 and April this year, the data shows. Some of the biggest spending drug companies included BMS, Novartis, Amgen, Pfizer, Roche and AstraZeneca. While most payments were between $500 and $5000 – including travel,... Read more
3d
Boston Globe
Congressmen want biotechs to explain MS drug pricesassistance programs, and drug distribution systems. Other companies with a loca
Boston Globe / Posted 3 days ago
assistance programs, and drug distribution systems. Other companies with a local presence were sent letters, including Novartis International AG — a Swiss company with its research and development headquarters in Cambridge — and French drug... Read more
4 related articles
3d
Daily Mirror
Black woman slowly turning white 'due to rare side effect of cancer treatment'just for black and Afro-Caribbean people though. "People hide when they've got
Daily Mirror / Posted 3 days ago
just for black and Afro-Caribbean people though. "People hide when they've got cancer - you only hear they have got it when they've passed. "They miss out on valuable support." The Mirror has approached Novartis, the maker of Votrient, for comme... Read more
3d
Swissinfo
Swiss companies pull out of Venezuelainflation and acute food shortages. Monitoring the situation Le Temps also me
Swissinfo / Posted 3 days ago
inflation and acute food shortages. Monitoring the situation Le Temps also mentioned Basel-based pharmaceutical giant Novartis, which was seriously reducing its operations. “Having once employed up to 600 workers in various offices around the... Read more
3d
Crain's Chicago Business
Foreign-born CEOs increasingly run Chicago multinationals - CahillVan de Put at McCain Foods in Canada. A Belgian, he led McCain for six years, a
Crain's Chicago Business / Posted 3 days ago
Van de Put at McCain Foods in Canada. A Belgian, he led McCain for six years, after stints at Swiss pharmaceutical company Novartis, French packaged-foods supplier Groupe Danone and the overseas operations of Mars and Coca-Cola. Executives with... Read more
3d
Business Wire
Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitiscompanies. In 2016 the most commercially successful companies in the therapy ar
Business Wire / Posted 3 days ago
companies. In 2016 the most commercially successful companies in the therapy area were Johnson & Johnson, AbbVie, Amgen, Novartis and Pfizer. Across the forecast period these companies will continue to generate high revenue, but the companies... Read more
3d
FOX Business
Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?Despite the little bit of skepticism there is about whether or not this drug wi
FOX Business / Posted 3 days ago
Despite the little bit of skepticism there is about whether or not this drug will be able to outperform drugs like Novartis' Cosentyx, there's also competition from the likes of GlaxoSmithKline, it's definitely not a market that they have... Read more
3d
FOX Business
Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?Despite the little bit of skepticism there is about whether or not this drug wi
FOX Business / Posted 3 days ago
Despite the little bit of skepticism there is about whether or not this drug will be able to outperform drugs like Novartis' Cosentyx, there's also competition from the likes of GlaxoSmithKline, it's definitely not a market that they have... Read more
4d
Swissinfo
House Democrats Start Probe Into Multiple Sclerosis Drug Pricesthe latest attempt by U.S. politicians to pressure manufacturers to lower costs
Swissinfo / Posted 4 days ago
the latest attempt by U.S. politicians to pressure manufacturers to lower costs. Seven drugmakers -- Biogen Inc., Sanofi, Novartis AG, Roche Holding AG, Bayer AG, Merck KGaA’s EMD Serono unit and Teva Phamaceuticals Industries Ltd. -- received... Read more
4 related articles
4d
NJ.com
College to hold memorial service for Marine killed by ex-boyfriendpolice about harassment by Shahid but she didn't file for a restraining order.
NJ.com / Posted 4 days ago
police about harassment by Shahid but she didn't file for a restraining order. Chasmar and Shahid were both employees of Novartis and worked at the company's manufacturing facility in Morris Plains. Druetzler also said Shahid borrowed a car to... Read more
4d
Philly.com
Teva is said to ramp up sales with Medis, respiratory unitsand pain treatments. The cancer and pain treatments have drawn interest from dr
Philly.com / Posted 4 days ago
and pain treatments. The cancer and pain treatments have drawn interest from drugmakers such as Fresenius SE, Mylan NV, Novartis AG, people familiar with the matter have said. Women’s health has also attracted drugmakers and private equity... Read more
4d
Reuters
House Democrats launch probe into MS drug pricingdrugmakers. U.S. Representatives Elijah Cummings and Peter Welch sent the lett
Reuters / Posted 4 days ago
drugmakers. U.S. Representatives Elijah Cummings and Peter Welch sent the letters to Bayer AG, Biogen Inc, EMD Serono, Novartis AG, Roche Holding AG, Sanofi SA, and Teva Pharmaceutical Industries Inc. The lawmakers said in the letters that... Read more
4 related articles
4d
Channel NewsAsia
House Democrats launch probe into MS drug pricingdrugmakers. U.S. Representatives Elijah Cummings and Peter Welch sent the lett
Channel NewsAsia / Posted 4 days ago
drugmakers. U.S. Representatives Elijah Cummings and Peter Welch sent the letters to Bayer AG, Biogen Inc, EMD Serono, Novartis AG, Roche Holding AG, Sanofi SA, and Teva Pharmaceutical Industries Inc. (Reporting by Michael Erman; Editing by... Read more
4 related articles
4d
Business Wire
PsiOxus Therapeutics Announce Two New Board Appointments: New Board Appointments Strengthen Company’s US Presencecareer, Charles held finance and operational positions at Biovail Pharmaceutica
Business Wire / Posted 4 days ago
career, Charles held finance and operational positions at Biovail Pharmaceuticals, Breakaway Technologies, Pharmacia, Novartis and Bristol-Myers Squibb. He currently serves as a member of the board of directors for Blueprint Medicines, Nabriva... Read more
5d
Canberra Times
Don't create policy, tax uncertainty: CSL's CEO Paul Perreault call to the Turnbull governmentis unmatched in the industry," Mr Perreault said. It still has not made a retu
Canberra Times / Posted 5 days ago
is unmatched in the industry," Mr Perreault said. It still has not made a return on the $US275 million acquisition of the Novartis influenza business, which is now called Seqirus. But Mr Perreault said it had secured multiple new product... Read more
5 related articles
6d
Brisbane Times
Don't create policy, tax uncertainty: CSL's CEO Paul Perreault call to the Turnbull governmentis unmatched in the industry," Mr Perreault said. It still has not made a retu
Brisbane Times / Posted 6 days ago
is unmatched in the industry," Mr Perreault said. It still has not made a return on the $US275 million acquisition of the Novartis influenza business, which is now called Seqirus. But Mr Perreault said it had secured multiple new product... Read more
5 related articles
6d
WA Today
Don't create policy, tax uncertainty: CSL's CEO Paul Perreault call to the Turnbull governmentis unmatched in the industry," Mr Perreault said. It still has not made a retu
WA Today / Posted 6 days ago
is unmatched in the industry," Mr Perreault said. It still has not made a return on the $US275 million acquisition of the Novartis influenza business, which is now called Seqirus. But Mr Perreault said it had secured multiple new product... Read more
5 related articles
6d
The Age
Don't create policy, tax uncertainty: CSL's CEO Paul Perreault call to the Turnbull governmentis unmatched in the industry," Mr Perreault said. It still has not made a retu
The Age / Posted 6 days ago
is unmatched in the industry," Mr Perreault said. It still has not made a return on the $US275 million acquisition of the Novartis influenza business, which is now called Seqirus. But Mr Perreault said it had secured multiple new product... Read more
5 related articles
6d
Sydney Morning Herald
Don't create policy, tax uncertainty: CSL's CEO Paul Perreault call to the Turnbull governmentis unmatched in the industry," Mr Perreault said. It still has not made a retu
Sydney Morning Herald / Posted 6 days ago
is unmatched in the industry," Mr Perreault said. It still has not made a return on the $US275 million acquisition of the Novartis influenza business, which is now called Seqirus. But Mr Perreault said it had secured multiple new product... Read more
5 related articles
6d
Business Insider Australia
CSL is positive on its outlook after a 7.4% rise in net profitprevious year’s results were hampered by the purchase of a loss-making subsidia
Business Insider Australia / Posted 6 days ago
previous year’s results were hampered by the purchase of a loss-making subsidiary of Swiss pharmaceutical multinational Novartis for $US275 million ($357 million). “We delivered on our promise to provide innovative medicines to patients with... Read more
6d
The Courier
Things to do in Basel, Switzerland: A three-minute guidesee it. Among its best buildings are the Children's Hospital on Spitalstrasse,
The Courier / Posted 6 days ago
see it. Among its best buildings are the Children's Hospital on Spitalstrasse, Frank Gehry's cloud-like office block on the Novartis campus, and St Jakob-Park stadium, designed by Basel company Herzog & de Meuron of Beijing's Bird's Nest fame. Just... Read more
6d
Business Wire
Global Sickle Cell Market Report 2017 - Industry Analysis & Outlook 2020-2030market, covering the U.S. and Europe along with the global market. The report p
Business Wire / Posted 6 days ago
market, covering the U.S. and Europe along with the global market. The report profiles key players of the market including Novartis, Bristol-Myers Squibb, Shire Plc, Bluebird Bio and Global Blood Therapeutics Inc. The U.S. is expected to be the... Read more
6d
PRWeek US
Johnson & Johnson in breach of UK drugs rules over Nicorette marketingmagazine Pulse for Nicorette. All three of those complaints came unnamed healt
PRWeek US / Posted 6 days ago
magazine Pulse for Nicorette. All three of those complaints came unnamed health professionals working as a consultant to Novartis - it is not known whether this was the same consultant in each instance - although in each case Novartis said it was... Read more
6d
PRWeek UK
Johnson & Johnson in breach of UK drugs rules over Nicorette marketingmagazine Pulse for Nicorette. All three of those complaints came unnamed healt
PRWeek UK / Posted 6 days ago
magazine Pulse for Nicorette. All three of those complaints came unnamed health professionals working as a consultant to Novartis - it is not known whether this was the same consultant in each instance - although in each case Novartis said it was... Read more
6d
Motley Fool
How to get exposure to the NASDAQ and European shares on the ASXFTSE Europe ETF provides diversification to some of Europe’s biggest companies
Motley Fool / Posted 6 days ago
FTSE Europe ETF provides diversification to some of Europe’s biggest companies like Nestle SA, Royal Dutch Shell plc and Novartis AG for a slightly smaller management fee of 0.35% per annum. The ETF additionally provides investors a quarterly... Read more
7d
FOX Business
3 Stocks to Buy With Dividends Yielding More Than 3%their returns. Among above-average yielding stocks, Darden Restaurants (NYSE: D
FOX Business / Posted 7 days ago
their returns. Among above-average yielding stocks, Darden Restaurants (NYSE: DRI), Cypress Semiconductor (NASDAQ: CY), and Novartis (NYSE: NVS) all have dividend yields of more than 3% and good potential for the future. Getting hungry... Read more
7d
FOX Business
3 Stocks to Buy With Dividends Yielding More Than 3%their returns. Among above-average yielding stocks, Darden Restaurants (NYSE: D
FOX Business / Posted 7 days ago
their returns. Among above-average yielding stocks, Darden Restaurants (NYSE: DRI), Cypress Semiconductor (NASDAQ: CY), and Novartis (NYSE: NVS) all have dividend yields of more than 3% and good potential for the future. Continue Reading... Read more
7d
Business Wire
LASIK Surgery Market - Forecasts and Opportunity Assessment by Technavioall geographical regions. The LASIK surgery market is consolidated with high c
Business Wire / Posted 7 days ago
all geographical regions. The LASIK surgery market is consolidated with high competition among the leading players such as Novartis, Johnson & Johnson, Valeant Pharmaceuticals International, Carl Zeiss, and Nidek while other players have limited... Read more
7d
BBC News
Trump: Pharmaceutical executives told to cut drug pricesprice hikes in some older generic drugs. Among those attending the meeting wer
BBC News / Posted 7 days ago
price hikes in some older generic drugs. Among those attending the meeting were the bosses of Merck, Johnson & Johnson, Novartis, Amgen and the head of the Pharmaceutical Research and Manufacturers of America (PhRMA) lobbying group. "US drug... Read more
7d
Business Wire
Corporate Reputation of Pharma Companies, 2016- Perspective of 100 German Patient Groupsfamiliar in 2016 was Roche (73 of the 100 respondent German patient groups were
Business Wire / Posted 7 days ago
familiar in 2016 was Roche (73 of the 100 respondent German patient groups were familiar with the company), followed by Novartis (71), and Pfizer (69). INDIVIDUAL COMPANY FINDINGS GERMANY Amgen (new to the German analysis) ranked overall 1st... Read more
8d
Crain's Detroit Business
UM's Glick talks drug discovery, investment and working the day after a big dealIFM is venture-backed, from firms such as Atlas Venture of Cambridge, Mass., an
Crain's Detroit Business / Posted 8 days ago
IFM is venture-backed, from firms such as Atlas Venture of Cambridge, Mass., and Boston-based Abingworth and drug company Novartis. It raised $27 million in series A funding in 2016, creating a 10-times return for investors just on the up front... Read more
9d
The Economic Times
Billionaire Dilip Shanghvi offers mea culpa after Sun Pharma lossfrom the previous year to $351 million, though the earlier period included excl
The Economic Times / Posted 9 days ago
from the previous year to $351 million, though the earlier period included exclusive rights to sell generic versions of Novartis AG’s blockbuster cancer drug Gleevec that expired in July of last year, the company said in its press... Read more
11d
Kiplinger.com
7 Reliable Dividend Stocks to Buy NowSwitzerland-based Novartis lost patent protection for its best-selling cancer d
Kiplinger.com / Posted 11 days ago
Switzerland-based Novartis lost patent protection for its best-selling cancer drug, Gleevec, last year—a product once worth nearly $5 billion in annual sales. Yet while sales of Gleevec have fallen sharply—to $506 million in the second quarter, down... Read more
11d
FOX Business
Lower drug prices burn pharma companies, benefit consumersdrugmaker plunged 18% following the announcement of second quarter earnings tha
FOX Business / Posted 11 days ago
drugmaker plunged 18% following the announcement of second quarter earnings that missed analyst expectations. Last month, Novartis’ generic drug branch, Sandoz, reported that sales fell 15% in the United States during the second quarter due to... Read more
4 related articles
11d
FOX Business
Lower drug prices burn pharma companies, benefit consumersdrugmaker plunged 18% following the announcement of second quarter earnings tha
FOX Business / Posted 11 days ago
drugmaker plunged 18% following the announcement of second quarter earnings that missed analyst expectations. Last month, Novartis’ generic drug branch, Sandoz, reported that sales fell 15% in the United States during the second quarter due to... Read more
4 related articles
12d
dna
India lags in pharma innovationPharma is bullish in China. Lung, liver and stomach cancers are among the top k
dna / Posted 12 days ago
Pharma is bullish in China. Lung, liver and stomach cancers are among the top killers in China, says the WHO. Novartis AG is testing a clinical candidate to treat head and neck cancer widespread in southern China. Johnson & Johnson’s (JNJ) portfolio... Read more
12d
Philly.com
An $872 million week for Philly biotech companiesInc., a Malvern developer of antibiotics for drug-resistant infections, run by
Philly.com / Posted 12 days ago
Inc., a Malvern developer of antibiotics for drug-resistant infections, run by Christopher J. Burns, formerly of Novartis’ Protez division. Versant also boasts a National Institutes of Health grant and funding from London-based Wellcome... Read more
12d
The Irish Times
Mylan slashes earnings forecast on US generics price cutsand pain treatments. The cancer and pain treatments have drawn interest from M
The Irish Times / Posted 12 days ago
and pain treatments. The cancer and pain treatments have drawn interest from Mylan as well as rivals Fresenius and Novartis, people familiar with the matter have said. Women’s health has also attracted drugmakers and private equity firms,... Read more
7 related articles
12d
NJ.com
Marine shot to death by ex-boyfriend tried to flee her killer, mayor sayspolice, Mayor Frank Druetzler said Tuesday. Shahid, 32, lived in Jersey City.
NJ.com / Posted 12 days ago
police, Mayor Frank Druetzler said Tuesday. Shahid, 32, lived in Jersey City. Both he and Chasmar, 28, were employees of Novartis, the international pharmaceutical company, and worked at the company's manufacturing facility in Morris... Read more
12d
Morningstar
High-Quality International Stocks for a Slim Feesuch as consumer staples and healthcare. Top holdings include major multination
Morningstar / Posted 12 days ago
such as consumer staples and healthcare. Top holdings include major multinational firms including Nestle , Roche , and Novartis . Companies such as these tend to be less volatile than the broader market, and should hold up better during market... Read more
13d
Business Wire
Model N Announces Third Quarter of Fiscal Year 2017 Financial Resultstechnology and manufacturing across more than 120 countries, including Johnson
Business Wire / Posted 13 days ago
technology and manufacturing across more than 120 countries, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology and Fairchild. For more information, visit www.modeln.com. Model N® is the registered... Read more
58 related articles
13d
New Kerala
Ionis Provides Improved 2017 Guidance Following Strong Financial Performance - newkerala news #261237completed its IPO in which it raised more than $190 million, including the $25
New Kerala / Posted 13 days ago
completed its IPO in which it raised more than $190 million, including the $25 million we invested and the $50 million Novartis AG invested. The IPO was an important step in our strategy to maximize the value of our broad pipeline. As an... Read more
13d
Reuters
Drugmakers' hopes for gene therapy rise despite tiny sales in Europe(ONCE.O) hopes to win U.S. approval in January 2018 for a gene therapy to cure
Reuters / Posted 13 days ago
(ONCE.O) hopes to win U.S. approval in January 2018 for a gene therapy to cure a rare inherited form of blindness, while Novartis (NOVN.S) could get a U.S. go-ahead as early as next month for its gene-modified cell therapy against leukaemia - a... Read more
13d
Business Wire
Cell Therapy Pioneer David Epstein Expands Role with Rubius Therapeutics to Become Executive Chairmanand potentially life-saving cellular therapies, today announced that David Epst
Business Wire / Posted 13 days ago
and potentially life-saving cellular therapies, today announced that David Epstein, previously chief executive officer of Novartis Pharmaceuticals, has expanded his role at Rubius to become executive chairman. Epstein was one of the first to... Read more
14d
NJ.com
Authorities identify man, woman in fatal Morris Plains shootingshortly afterwards, the prosecutor's office said. Mayor Frank Deutzler told th
NJ.com / Posted 14 days ago
shortly afterwards, the prosecutor's office said. Mayor Frank Deutzler told the Daily Record that Shahid, a co-worker at Novartis who used to date Chasmar, ambushed the woman before running off and killing himself. Chasmar had complained to... Read more
14d
Business Standard India
Indian pharma poised for US acquisitionsthat it might breach some debt covenants this year if sales did not rise. Soon,
Business Standard India / Posted 14 days ago
that it might breach some debt covenants this year if sales did not rise. Soon, names of drug makers Fresenius, Mylan and Novartis started doing the rounds as buyers of some of Teva's ... Key stories on business-standard.com are available to... Read more
More

In this news